ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy

MLA

Ren Zhu, et al. “ROS-Cleavable Diselenide Nanomedicine for NIR-Controlled Drug Release and on-Demand Synergistic Chemo-Photodynamic Therapy.” Acta Biomaterialia, vol. 153, May 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0f11567f7b885dadf770282e984da80d&authtype=sso&custid=ns315887.

APA

Ren Zhu, Qi He, Zhiling Li, Yuhao Ren, Yixian Liao, Zejun Zhang, Quan Dai, Chengying Wan, Sihui Long, Lingyi Kong, Wenpei Fan, & Wenying Yu. (2022). ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy. Acta Biomaterialia, 153.

Chicago

Ren Zhu, Qi He, Zhiling Li, Yuhao Ren, Yixian Liao, Zejun Zhang, Quan Dai, et al. 2022. “ROS-Cleavable Diselenide Nanomedicine for NIR-Controlled Drug Release and on-Demand Synergistic Chemo-Photodynamic Therapy.” Acta Biomaterialia 153 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0f11567f7b885dadf770282e984da80d&authtype=sso&custid=ns315887.